Literature DB >> 14534048

Incidence of surgery in conservatively treated patients with scoliosis.

Hans-Rudolf Weiss1, Grita Weiss, Hans-Jürgen Schaar.   

Abstract

UNLABELLED: The effectiveness of bracing and the effectiveness of conservative treatment of scoliosis as a whole is widely denied and rejected. We therefore carried out the present study in order to establish whether the work involved in the conservative treatment of scoliosis is reasonable and worthwhile, including as it does the education of patients, techniques of brace moulding, time-consuming follow-ups and the strain put on patients by the treatment itself. STUDY
DESIGN: A retrospective analysis of the incidence of surgery in patients with scoliosis presenting every kind of aetiology. To improve comparison with data already published by other centres, this group of patients was matched with the study design of the control group.
MATERIALS AND METHODS: Since 1992, in addition to the intensive inpatient rehabilitation programme developed at our centre, we have also been practising moulding techniques according to Chêneau in order to construct scoliosis orthoses of high correction. For the purposes of this study we chose a number of scoliosis patients from our data bank who had had conservative treatment at our centre between 1993 and 1996. All the patients, like those of the untreated control group, were at least 15 years of age at the time they were last investigated or questioned. The incidence of surgery in our group was compared statistically with data published by other centres.
RESULTS: Three hundred and forty-three patients (females only) with a curvature of 33.4 degrees (SD = 18.9) were included in our study and could be followed up under the described pre-conditions. Forty-one patients (11.95%) had had surgery. In patients with adolescent idiopathic scoliosis, we found an incidence of surgery of only 7.3% compared with 28% in the control group with the same diagnosis. Statistically, therefore, the incidence of surgery in our group was highly significantly lower than the incidence of surgery in the control group from Ireland and other centres described in literature.
CONCLUSIONS: The conservative treatment of scoliosis (which includes outpatient physiotherapy, inpatient intensive scoliosis rehabilitation (SIR) and high-correction-effect bracing based on plastercasting) shows an obvious reduction in the rate of surgery in patients with idiopathic scoliosis compared with untreated scoliosis patients. Thus it can be seen that the conservative treatment of scoliosis may reduce the incidence of surgery, which not only causes considerable medical expenses but also carries with it the risk of repeated operations and further complications. In our study, we also found highly significant differences by comparison with the work of a bracing centre in the USA. Therefore, the quality of the bracing itself and the effects of primary correction must receive greater consideration in future scientific studies on the subject of "conservative" treatment of scoliosis.

Entities:  

Mesh:

Year:  2003        PMID: 14534048     DOI: 10.1080/13638490310001593446

Source DB:  PubMed          Journal:  Pediatr Rehabil        ISSN: 1363-8491


  28 in total

1.  Idiopathic scoliosis in Korean schoolchildren: a prospective screening study of over 1 million children.

Authors:  Seung-Woo Suh; Hitesh N Modi; Jae-Hyuk Yang; Jae-Young Hong
Journal:  Eur Spine J       Date:  2011-01-28       Impact factor: 3.134

2.  Brace technology thematic series: the 3D Rigo Chêneau-type brace.

Authors:  Manuel Rigo; Mina Jelačić
Journal:  Scoliosis Spinal Disord       Date:  2017-03-16

Review 3.  Adolescent idiopathic scoliosis: indications for bracing and conservative treatments.

Authors:  André J Kaelin
Journal:  Ann Transl Med       Date:  2020-01

Review 4.  Exercises for adolescent idiopathic scoliosis.

Authors:  Michele Romano; Silvia Minozzi; Josette Bettany-Saltikov; Fabio Zaina; Nachiappan Chockalingam; Tomasz Kotwicki; Axel Maier-Hennes; Stefano Negrini
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

5.  Chêneau brace for adolescent idiopathic scoliosis: long-term results. Can it prevent surgery?

Authors:  S De Giorgi; A Piazzolla; S Tafuri; C Borracci; A Martucci; G De Giorgi
Journal:  Eur Spine J       Date:  2013-09-17       Impact factor: 3.134

6.  "Brace Technology" Thematic Series - The ScoliOlogiC® Chêneau light™ brace in the treatment of scoliosis.

Authors:  Hans-Rudolf Weiss; Mario Werkmann
Journal:  Scoliosis       Date:  2010-09-06

Review 7.  2016 SOSORT guidelines: orthopaedic and rehabilitation treatment of idiopathic scoliosis during growth.

Authors:  Stefano Negrini; Sabrina Donzelli; Angelo Gabriele Aulisa; Dariusz Czaprowski; Sanja Schreiber; Jean Claude de Mauroy; Helmut Diers; Theodoros B Grivas; Patrick Knott; Tomasz Kotwicki; Andrea Lebel; Cindy Marti; Toru Maruyama; Joe O'Brien; Nigel Price; Eric Parent; Manuel Rigo; Michele Romano; Luke Stikeleather; James Wynne; Fabio Zaina
Journal:  Scoliosis Spinal Disord       Date:  2018-01-10

8.  Team care to cure adolescents with braces (avoiding low quality of life, pain and bad compliance): a case-control retrospective study. 2011 SOSORT Award winner.

Authors:  Marta Tavernaro; Anna Pellegrini; Fabrizio Tessadri; Fabio Zaina; Andrea Zonta; Stefano Negrini
Journal:  Scoliosis       Date:  2012-09-20

9.  Guidelines on "Standards of management of idiopathic scoliosis with corrective braces in everyday clinics and in clinical research": SOSORT Consensus 2008.

Authors:  Stefano Negrini; Theodoros B Grivas; Tomasz Kotwicki; Manuel Rigo; Fabio Zaina
Journal:  Scoliosis       Date:  2009-01-16

10.  Treatment of thoraco-lumbar curves in adolescent females affected by idiopathic scoliosis with a progressive action short brace (PASB): assessment of results according to the SRS committee on bracing and nonoperative management standardization criteria.

Authors:  Angelo G Aulisa; Vincenzo Guzzanti; Marco Galli; Carlo Perisano; Francesco Falciglia; Lorenzo Aulisa
Journal:  Scoliosis       Date:  2009-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.